Formulation and characterization of a captopril ethyl ester drug-in-adhesive-type patch for percutaneous absorption

Drug Development and Industrial Pharmacy

Volumn 36, Issue 8, 2010, Pages 926-932

  Gullick, Darren R ^a   Pugh, W John ^b   Ingram, Matthew J ^c   Cox, Paul A ^a   Moss, Gary P ^d  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF BRIGHTON   (United Kingdom)

^d KEELE UNIVERSITY   (United Kingdom)

Author keywords

Captopril; Drug in adhesive formulation; Percutaneous absorption; Texture profile analysis; Transdermal drug delivery

Indexed keywords

CAPTOPRIL; CAPTOPRIL ETHYL ESTER; SILASTIC; UNCLASSIFIED DRUG; ADHESIVE AGENT; ANTIHYPERTENSIVE AGENT; DIMETICONE; ESTER; POLYMER; PRODRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; DRUG FORMULATION; DRUG RELEASE; INFRARED SPECTROSCOPY; MICROSCOPY; NONHUMAN; PORCINE ADENOVIRUS; PREFORMULATION; SKIN ABSORPTION; SWINE; TRANSDERMAL PATCH; ADHESION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; INFRARED SPECTROPHOTOMETRY; INTRADERMAL DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; METABOLISM; PERMEABILITY; PHYSICAL CHEMISTRY; SKIN; TIME;

ADHESIVENESS; ADHESIVES; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CAPTOPRIL; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; DIMETHYLPOLYSILOXANES; DRUG DELIVERY SYSTEMS; ESTERS; PERMEABILITY; PHYSICOCHEMICAL PHENOMENA; POLYMERS; PRODRUGS; SKIN; SKIN ABSORPTION; SPECTROPHOTOMETRY, INFRARED; SUS SCROFA; TIME FACTORS;

EID: 77954192543     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903585135     Document Type: Article

References (20)

1. JainPharmaBiotech.(2009). Markets for transdermal drug delivery, Ch. 4. In: Transdermal drug delivery\technologies, markets, and companies. Basel.100-107
2. Tanner T, Marks R. (2008). Delivering drugs by the transdermal route: Review and comment. Skin Res Technol, 14:249-260
3. Moss GP, Gullick DR, Cox PA, Alexander C, Ingram MJ, Smart JD, et al. (2006). Design, synthesis and characterization of cap-topril prodrugs for enhanced percutaneous absorption. J Pharm Pharmacol, 58:167-177
4. Gullick DR, Ingram MJ, Pugh WJ, Cox PA, Gard P, Smart JD, et al. (2009). Metabolism of captopril carboxyl ester derivatives for percutaneous absorption. J Pharm Pharmacol, 61:159-165
5. Schulz M, Schmoldt A. (2003). Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie, 58:447-474
6. Woolfson AD, McCafferty DF, Moss GP. (1998). Development and characterisation of a moisture-activated bioadhesive drug delivery system for percutaneous local anaesthesia. Int J Pharm, 169:83.
7. Nalluri BN, Milligan C, Jianhong C, Crooks PA, Stinchcomb AL. (2005). In vitro release studies on matrix type transdermal drug delivery systems of naltrexone and its acetyl pro drug. Drug Dev Ind Pharm, 31:871.
8. Jones DS, Woolfson AD, Brown AF. (1997). Textural, viscoelas-tic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm, 151:223.
9. Heard CM, Johnson S, Moss G, Thomas CP. (2006). In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of Guarana, Paullinia Cupana. Int J Pharm, 317:26-31.
10. Taylor LJ, Lee RS, Long M, Rawlings AV, Tubek J, Whitehead L, et al. (2002). Effect of occlusion on the percutaneous penetration of linoleic acid and glycerol. Int J Pharm, 249:157-164
11. He Y, Zhu B, Inoue Y. (2004). Hydrogen bonds in polymer blends. Prog Polym Sci, 29:1021-1051
12. Lawson AAH. (1985). Clinical and pharmacological studies with transdermal clonidine. In: Prescott LF, Nimmo WS, eds. Rate control of drug therapy. Edinburgh: Churchill Livingstone.
13. Baker RW, Heller J. (1989). Materials selection for transdermal delivery systems. In: Hadgraft J, Guy RH, eds. Transdermal drug delivery\developmental issues and research initiatives. New York: Dekker.
14. Williams AC. (2003). Topical and transdermal formulations, Ch. 6. In: Transdermal and topical drug delivery from theory to clinical practice. London: Pharmaceutical Press, 169-194
15. Mehdizadeh A, Ghahremani MH, Rouini MR, Toliyat T. (2006). Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin. Acta Pharm, 56:219-229
16. ASTM. (1992). D882-91 standard test methods for tensile properties of thin plastic sheeting. Philadelphia, PA: American Society for the Testing of Materials.
17. Woolfson AD, Malcolm RK, Campbell K, Jones DS, Russell JA. (2000). Rheological, mechanical and membrane penetration properties of novel dual drug systems for percutaneous delivery. J Control Release, 67:395.
18. Jones DS, Woolfson AD, Brown AF. (1997). Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharm Res, 14:450.
19. Dennis AC, McGarvey JJ, Woolfson AD, McCafferty DF, Moss GP. (2004). A Raman spectroscopic investigation of bioadhe-sive tetracaine local anaesthetic formulations. Int J Pharm, 279:43-50.
20. Lin-Vien D, Colthup NB, Fateley WG, Grasselli JG. (1991). The handbook of infrared and Raman characteristic frequencies of organic molecules. Orlando: Academic Press.